FR2340955A1 - Produit de dissociation du virus de la rage, son procede d'obtention et vaccin le contenant - Google Patents

Produit de dissociation du virus de la rage, son procede d'obtention et vaccin le contenant

Info

Publication number
FR2340955A1
FR2340955A1 FR7703023A FR7703023A FR2340955A1 FR 2340955 A1 FR2340955 A1 FR 2340955A1 FR 7703023 A FR7703023 A FR 7703023A FR 7703023 A FR7703023 A FR 7703023A FR 2340955 A1 FR2340955 A1 FR 2340955A1
Authority
FR
France
Prior art keywords
obtaining
rabies virus
vaccine containing
dissociation product
dissociation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7703023A
Other languages
English (en)
French (fr)
Other versions
FR2340955B1 (ref
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of FR2340955A1 publication Critical patent/FR2340955A1/fr
Application granted granted Critical
Publication of FR2340955B1 publication Critical patent/FR2340955B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
FR7703023A 1976-02-12 1977-02-03 Produit de dissociation du virus de la rage, son procede d'obtention et vaccin le contenant Granted FR2340955A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2605469A DE2605469C3 (de) 1976-02-12 1976-02-12 Verfahren zur Gewinnung eines Spaltprodukts des Tollwut-Virus und dieses enthaltender Impfstoff

Publications (2)

Publication Number Publication Date
FR2340955A1 true FR2340955A1 (fr) 1977-09-09
FR2340955B1 FR2340955B1 (ref) 1979-03-02

Family

ID=5969649

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7703023A Granted FR2340955A1 (fr) 1976-02-12 1977-02-03 Produit de dissociation du virus de la rage, son procede d'obtention et vaccin le contenant

Country Status (15)

Country Link
JP (1) JPS5299209A (ref)
AT (1) AT350715B (ref)
BE (1) BE851404A (ref)
CA (1) CA1087982A (ref)
CH (1) CH638562A5 (ref)
DE (1) DE2605469C3 (ref)
DK (1) DK145580C (ref)
FR (1) FR2340955A1 (ref)
GB (1) GB1567547A (ref)
IE (1) IE44440B1 (ref)
IL (1) IL51412A (ref)
IT (1) IT1075115B (ref)
LU (1) LU76737A1 (ref)
NL (1) NL7701255A (ref)
OA (1) OA05567A (ref)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049296B1 (en) * 1980-10-02 1985-03-27 Schering Corporation Injectable rabies vaccine composition and method for preparing same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049296B1 (en) * 1980-10-02 1985-03-27 Schering Corporation Injectable rabies vaccine composition and method for preparing same

Also Published As

Publication number Publication date
DK145580C (da) 1983-05-16
OA05567A (fr) 1981-04-30
ATA92877A (de) 1978-11-15
IT1075115B (it) 1985-04-22
BE851404A (fr) 1977-08-16
CH638562A5 (en) 1983-09-30
DK145580B (da) 1982-12-13
DE2605469A1 (de) 1977-09-15
GB1567547A (en) 1980-05-14
CA1087982A (en) 1980-10-21
DE2605469C3 (de) 1980-04-10
FR2340955B1 (ref) 1979-03-02
JPS5299209A (en) 1977-08-19
IE44440L (en) 1977-08-12
AT350715B (de) 1979-06-11
DE2605469B2 (de) 1979-08-02
IL51412A0 (en) 1977-04-29
DK59377A (da) 1977-08-13
IL51412A (en) 1980-05-30
NL7701255A (nl) 1977-08-16
LU76737A1 (ref) 1977-08-19
IE44440B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
FR2293928A1 (fr) Nouveaux derives d'acide 3-amino-indazolecarboxylique, leur procede de preparation et medicament les contenant
FR2331340A1 (fr) Nouveaux derives du benzimidazole, procede pour leur obtention et compositions pharmaceutiques les contenant
BE860726A (fr) Nouveaux aryl-acylamides n-(2-aminocy-cloaliphatiques), leur procede de preparation et medicament les contenant
BE827354A (fr) Nouveaux derives benzamidiques de pyrrolidine et piperidine, leur procede de preparation et medicament les contenant
BE860727A (fr) Nouveaux benzamides trans-n-(2-aminocycloaliphatiques), leur procede de preparation et medicament les contenant
FR2274289A1 (fr) Nouveaux derives d'acide oxy-16 prostanoique, leur procede de preparation et leur utilisation therapeutique
BE842310A (fr) Derives de la thieno-pyridine, leur procede de preparation et composition therapeutique les contenant
FR2273522A2 (fr) Nouveau derive d'alcanolamine, son procede de preparation et medicament le contenant
BE830211A (fr) Nouveaux amides d'acides carboxyliques, leur procede de preparation etmedicament les contenant
BE828686A (fr) Nouvel acide penicillanique, son procede de preparation et medicament le contenant
FR2353530A1 (fr) Nouveaux derives de guanidine, leur procede de preparation et composition pharmaceutique les contenant
BE879173A (fr) Procede de preparation d'un allergene traite par un aldehyde, produit obtenu et son application therapeutique
LU79422A1 (fr) Dipyrido(4,3-b)(3,4-f)indoles,procede d'obtention,application therapeutique et compositions pharmaceutiques les contenant
IT1044797B (it) Alti polimeri contenenti radicali prostaglandinici processo per la loro preparazione e loro impiego
FR2344531A1 (fr) Nouveaux derives de l'acide sulfonamidobenzoique, leur procede de preparation et medicaments les contenant
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
FR2287916A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et medicament les contenant
FR2315267A1 (fr) Nouvelle 1,9-lactone du type prostaglandine, son procede de preparation et medicament la contenant
FR2485537B2 (fr) Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
BE858269A (fr) Nouvelles aminoalkylidenamino-1,4-dihydropyridines, leur procede de preparation et medicament les contenant
FR2331343A1 (fr) Nouvelle spiro(1,3-dioxolane-4,3')quinuclidine, son procede de preparation et medicament la contenant
BE846146A (fr) Produit capillaire et son procede de preparation
FR2338938A1 (fr) Nouveaux derives de la piperazine et de ses homologues, leur procede de preparation et medicament les contenant
FR2340955A1 (fr) Produit de dissociation du virus de la rage, son procede d'obtention et vaccin le contenant
FR2334345A1 (fr) Nouveau derive d'alcool benzylique, son procede de preparation et medicament le contenant

Legal Events

Date Code Title Description
ST Notification of lapse